SCIENTIFIC BACKGROUND

DMPK

Category:

Myotonic dystrophies are multisystemic diseases with an autosomal dominant inheritance pattern that represent the most common muscular dystrophies in adults. The prevalence of myotonic dystrophy type 1 (DM1) is estimated at 1:8,000. Onset of symptoms, such as myotonia characterized by delayed relaxation of a tense muscle, is most often observed in early adulthood. In addition, there is muscle weakness and fatigue, as well as dysphagia, an elongated face with poor facial expression, cataracts, diabetes mellitus, and cardiac arrythmias; in men there is early development of a bald forehead and testicular atrophy. The clinical presentation of DM1 is categorized into four partially overlapping phenotypes: asymptomatic, mild, classic, and neonatal. The congenital form is characterized by pronounced muscle hypotonia, often clubfoot formation, and is usually associated with respiratory insufficiency difficulty drinking. Psychomotor development is often delayed. This type occurs predominantly when the disease is passed down from the mother and only in DM1.

 

DM1 is caused by a CTG repeat expansion in the non-translated 3' region of the DMPK gene on chromosome 19 which encodes a protein kinase. DM2 (proximal myotonic myopathy), which is important for differential diagnosis, is caused by expansion of a CCTG repeat in intron 1 of the ZNF9 gene on chromosome 3. The phenomenon of anticipation—meaning a decrease in the age of onset of the disease and/or an increase in the severity of symptoms from one generation to the next—is particularly pronounced in DM1. Healthy individuals have 5-36 CTG repeats in the DMPK gene while DM patients have up to approximately 1,000. Children with the congenital type have more than 1,000 repeats.

 

References

Ashizawa et al. 2018, Neurol Clin Pract 8:507 / Pratte et al. 2015, Am J Med Genet A 167A:708 / Turner et al. 2010, J Neurol Neurosurg Psychiatry 81:358 / Schara et al. 2006, Semin Pediatr Neurol 13:71  / Ranum et al. 2004, Am J Hum Genet 74:793 / Larkin et al. 2001, Brain Res Bull 56:389

GENES

DMPK

ASSOCIATED TESTS

How to order

LATEST ARTICLES

The endometrial microbiome is increasingly recognized as a factor in reproductive health, and imbalances in microbial composition have been linked to...

Read more

Spinal muscular atrophy is a rare genetic condition that weakens muscles by affecting the motor nerve cells in the spinal cord. It is a leading genet...

Read more

Summer encourages people to spend more time outdoors, soaking in the sun and enjoying the season’s warm weather. While sunlight can have beneficial...

Read more

We're thrilled to share the results of Medicover Genetics essay competition for high school students as well as the two winning essays. This competit...

Read more

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of...

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni...

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more